Literature DB >> 4114990

[Treatment with estramustine phosphate in advanced prostatic cancer].

D Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4114990

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


× No keyword cloud information.
  4 in total

Review 1.  Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response.

Authors:  David R Yates; Morgan Rouprêt
Journal:  World J Urol       Date:  2011-11-23       Impact factor: 4.226

2.  Estracyt in hormone-resistant prostatic carcinoma.

Authors:  Z Szendröi; I Könyves; L Szendi; S Eckhardt; F Hartay
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

Review 3.  Pharmacokinetics and pharmacodynamics of estramustine phosphate.

Authors:  A T Bergenheim; R Henriksson
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 4.  Estramustine in malignant glioma.

Authors:  A T Bergenheim; R Henriksson; J M Piepmeier; D Yoshida
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.